542 results on '"Geissler, Edward K."'
Search Results
2. Proteolytic shedding of CD46 from human hepatocytes indicates liver stress
3. Hepatitis E virus infection in immunosuppressed patients and its clinical manifestations
4. Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
5. Soluble CD46 as a diagnostic marker of hepatic steatosis
6. Donor antigen-specific regulatory T cell administration to recipients of live donor kidneys: A ONE Study consortium pilot trial
7. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
8. A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients
9. A non-canonical vitamin K cycle is a potent ferroptosis suppressor
10. Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER randomized clinical trial.
11. Establishing Guidelines for Organ Donation Systems
12. Incidence and Mortality of Malignant Melanoma in Relation to Dermatologist Density in Bavaria
13. Pressure distribution and flow characteristics during negative pressure wound therapy
14. Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
15. Successful auxiliary two-staged partial resection liver transplantation (ASPIRE-LTx) for end-stage liver disease to avoid small-for-size situations
16. Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis
17. Oxygen levels during negative pressure wound therapy
18. Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation.
19. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients
20. Inhibition of mTORC2/RICTOR Impairs Melanoma Hepatic Metastasis
21. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients
22. Novel GM-CSF signals via IFN-γR/IRF-1 and AKT/mTOR license monocytes for suppressor function
23. Negative pressure wound therapy (NPWT) on closed incisions to prevent surgical site infection in high-risk patients in hepatopancreatobiliary surgery: study protocol for a randomized controlled trial—the NP-SSI trial
24. Good outcomes after repeated pediatric liver retransplantations: A justified procedure even in times of organ shortage.
25. mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
26. Transplantation Direct: TTS eJournal Progress Update
27. Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function
28. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
29. IRAK-M Expression in Tumor Cells Supports Colorectal Cancer Progression through Reduction of Antimicrobial Defense and Stabilization of STAT3
30. RORγt+ IL-22-producing NKp46+ cells protect from hepatic ischemia reperfusion injury in mice
31. Anti-BAFF Treatment Interferes With Humoral Responses in a Model of Renal Transplantation in Rats
32. Can Mycophenolic Acid-based Immunosuppression Benefit Liver Transplant Patients With HCC?
33. Now or never? The case for cell-based immunosuppression in kidney transplantation
34. Extended Pancreas Donor Program—The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years
35. European Reflections on New Indications for Extracorporeal Photopheresis in Solid Organ Transplantation
36. Predicting Early Viral Control under DAA Therapy for Chronic HCV Using Pretreatment Immunological Markers
37. Early Enrichment and Restitution of the Peripheral Blood Treg Pool is Associated with Rejection-Free Stable Immunosuppression After Liver Transplantation
38. DHRS9 is a Stable Marker of Human Regulatory Macrophages
39. Generation of TIGIT+ iTregs by Human Regulatory Macrophages before Kidney Transplantation
40. BTNL8 is Expressed by Human Mreg-induced FOXP3+ iTregs
41. In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
42. Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response
43. Morbidity of hepatic resection for intermediate and advanced hepatocellular carcinoma
44. IFN-γ-induced iNOS Expression in Mouse Regulatory Macrophages Prolongs Allograft Survival in Fully Immunocompetent Recipients
45. DHRS9 Is a Stable Marker of Human Regulatory Macrophages
46. Bile duct regeneration and immune response by passenger lymphocytes signals biliary recovery versus complications after liver transplantation
47. Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation
48. STAT5b as Molecular Target in Pancreatic Cancer—Inhibition of Tumor Growth, Angiogenesis, and Metastases
49. Su1190 THERAPEUTICALLY FAVOURABLE IMMUNE PROFILE OF PATIENTS WITH PERITONEAL CARCINOMATOSIS SELECTED FOR CYTOREDUCTIVE SURGERY AND HIPEC THERAPY
50. Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.